. "clinical trial"@en . . "2015-12-01T00:00:00Z"^^ . "DUBLIN-3"@en . "Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC"@en . . . . . "Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC"@nl . . . . "18"^^ . . . . . "Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC"@en . "2019-10-01T00:00:00Z"^^ . . . . "NCT02504489" . . . . . . . . . "Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC"@en . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . "ensayu cl\u00EDnicu"@ast . . . . . "Randomized Blinded Phase III Assessment of Second or Third-Line Chemotherapy With Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced Non-Small Cell Lung Cancer and With at Least One Measurable Lung Lesion"@en . "Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC"@nl . . . . "klinisch onderzoek"@nl . "554"^^ . . . . . "Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC"@nl .